Harout Semerjian

CIK 1809747 · View on SEC EDGAR ↗

Insider

First SEC filing: Aug. 10, 2021 · Latest: Aug. 8, 2025

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

5 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Nov. 11, 2022 CBIO P 25,000 $1.29 $32,250 25,000 Direct Acquired -87.4% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Aug. 7, 2025 GERN Stock Option (right to buy) Common Stock (4,000,000) $1.30 Aug. 6, 2035 4,000,000 Acquired
Aug. 7, 2025 GERN Stock Option (right to buy) Common Stock (7,000,000) $1.30 Aug. 6, 2035 7,000,000 Acquired
Jan. 12, 2024 CBIO Employee Stock Option (right to buy) Common Stock (695,000) $3.11 Jan. 11, 2034 695,000 Acquired
Jan. 19, 2023 CBIO Employee Stock Option (right to buy) Common Stock (651,200) $2.55 Jan. 18, 2033 651,200 Acquired
Jan. 21, 2022 CBIO Employee Stock Option (right to buy) Common Stock (423,500) $1.11 Jan. 20, 2032 423,500 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Aug. 10, 2021 CBIO No securities beneficially owned 0 Direct
Aug. 10, 2021 CBIO Employee Stock Option (right to buy)→ Common Stock (1,098,400) 1,098,400 Direct
Aug. 10, 2021 CBIO Employee Stock Option (right to buy)→ Common Stock (549,200) 549,200 Direct